Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.
2.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

3.

Evidence of pre-procedural statin therapy a meta-analysis of randomized trials.

Winchester DE, Wen X, Xie L, Bavry AA.

J Am Coll Cardiol. 2010 Sep 28;56(14):1099-109. doi: 10.1016/j.jacc.2010.04.023. Epub 2010 Aug 31. Review.

4.

Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis.

Gutierrez J, Ramirez G, Rundek T, Sacco RL.

Arch Intern Med. 2012 Jun 25;172(12):909-19. doi: 10.1001/archinternmed.2012.2145. Review.

PMID:
22732744
5.

Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients.

Mills EJ, O'Regan C, Eyawo O, Wu P, Mills F, Berwanger O, Briel M.

Eur Heart J. 2011 Jun;32(11):1409-15. doi: 10.1093/eurheartj/ehr035. Epub 2011 Mar 8. Review.

PMID:
21385791
6.

Efficacy and safety of statin monotherapy in older adults: a meta-analysis.

Roberts CG, Guallar E, Rodriguez A.

J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):879-87. Review.

PMID:
17702880
7.

The effect of statins on average survival in randomised trials, an analysis of end point postponement.

Kristensen ML, Christensen PM, Hallas J.

BMJ Open. 2015 Sep 24;5(9):e007118. doi: 10.1136/bmjopen-2014-007118. Review.

8.

Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis.

Antoniou GA, Fisher RK, Georgiadis GS, Antoniou SA, Torella F.

Vascul Pharmacol. 2014 Nov;63(2):79-87. doi: 10.1016/j.vph.2014.09.001. Epub 2014 Oct 18. Review.

PMID:
25446168
9.

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.

Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, de Craen AJ, Knopp RH, Nakamura H, Ridker P, van Domburg R, Deckers JW.

BMJ. 2009 Jun 30;338:b2376. doi: 10.1136/bmj.b2376. Review.

10.

Statin treatment for patients with heart failure.

Tang WH, Francis GS.

Nat Rev Cardiol. 2010 May;7(5):249-55. doi: 10.1038/nrcardio.2010.29. Epub 2010 Mar 16. Review.

PMID:
20234351
11.

Statins in Primary Prevention: Uncertainties and Gaps in Randomized Trial Data.

Mansi IA.

Am J Cardiovasc Drugs. 2016 Dec;16(6):407-418. Review.

PMID:
27677504
12.

The spectrum of statin therapy in cancer patients: is there a need for further investigation?

Gonyeau MJ.

Curr Atheroscler Rep. 2014 Jan;16(1):383. doi: 10.1007/s11883-013-0383-z. Review.

PMID:
24306898
13.

Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.

Danaei G, Tavakkoli M, HernĂ¡n MA.

Am J Epidemiol. 2012 Feb 15;175(4):250-62. doi: 10.1093/aje/kwr301. Epub 2012 Jan 5. Review.

Supplemental Content

Support Center